CFTR and cystic fibrosis: For example, it may be possible to correct defects in biogenesis, trafficking, and function of citrin by appropriate small molecule therapy, as employed, for example, to overcome some of the pathogenic mutations that lead to cystic fibrosis by affecting the localization and function of the cystic fibrosis transmembrane conductance regulator (CFTR).47